BURZYNSKI RESEARCH INSTITUTE INC
BURZYNSKI RESEARCH INSTITUTE INC (BZYR): 4 pipeline candidates · ~0 mo cash runway · 3 clinical trials. Updated within the last hour.
BioSniper Score
4-factor signal · derived from public data
0.0 months
D/E -1.03 · 0% dilution
Lead: Phase 3
4 candidates
N/A
N/A
A transparent, data-derived signal for BURZYNSKI RESEARCH INSTITUTE INCacross cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$1.2M
Cash
$2K
Quarterly Burn
$823K
Runway
0.0 mo
Revenue
$0
Pipeline (4 candidates)
| Drug | Phase |
|---|---|
| A10 and AS2-1 Antineoplaston | Phase 3 |
| Antineoplastons (A10 & AS2-1) | Phase 3 |
| Antineoplastons (A10 and AS2-1) | Phase 3 |
| Antineoplastons A10 and AS2-1 | Phase 3 |
Frequently asked questions
How many drug candidates are in BURZYNSKI RESEARCH INSTITUTE INC's pipeline?
BURZYNSKI RESEARCH INSTITUTE INC (BZYR) has 4 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is BURZYNSKI RESEARCH INSTITUTE INC's lead drug candidate?
BURZYNSKI RESEARCH INSTITUTE INC's most advanced tracked candidate is A10 and AS2-1 Antineoplaston (Phase 3) for Treatment of various cancers; specifically brain stem glioma; gliomas; diffuse intrinsic pontine glioma (DIPG); primary malignant brain tumors; glioblastoma multiforme; anaplastic astrocytoma; pediatric brain tumors; optic/visual pathway glioma; primitive neuroectodermal tumors (PNET); low-grade astrocytoma; medulloblastoma; malignant meningioma; studied as adjuvant therapy after hepatectomy for liver metastases from colorectal cancer (per a published randomized Phase II study)..
What is BURZYNSKI RESEARCH INSTITUTE INC's cash runway?
Based on its most recent reported cash balance and quarterly burn rate, BURZYNSKI RESEARCH INSTITUTE INC has approximately 0.0 months of cash runway.
What is BURZYNSKI RESEARCH INSTITUTE INC's market capitalization?
BURZYNSKI RESEARCH INSTITUTE INC's market capitalization is approximately $1.2M.
Who is the CEO of BURZYNSKI RESEARCH INSTITUTE INC?
Dr. Stanislaw R. Burzynski M.D., Ph.D. is the chief executive officer of BURZYNSKI RESEARCH INSTITUTE INC (BZYR).
Get the full picture on BURZYNSKI RESEARCH INSTITUTE INC
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.